By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



CHNO des Quinze-Vingts
Résidence Saint Louis
Cedex    75571  France
Phone: 33-1-56-95-05-60 Fax: 33-1-56-95-05-69



Company News
Neurotech Announces First Patient Enrolled In Novel Anti-VEGF Encapsulated Cell Therapy Study 9/2/2015 8:04:21 AM
Neurotech Announces FDA Acceptance Of Investigational New Drug Application And Clinical Trial Initiation Of Novel Therapy For Wet AMD 3/30/2015 9:08:04 AM
Neurotech Announces Appointment Of Dr. Charles Johnson As Chief Medical Officer 3/18/2015 9:28:56 AM
Cognoptix President And CEO Paul Hartung Tells Neurotech Investors: "Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care." 4/25/2014 9:54:45 AM
Neurotech, To Present At Biotech Showcase 2014 In San Francisco 1/6/2014 7:09:33 AM
Neurotech Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies 9/19/2013 10:08:34 AM
James Mazzo Appointed Executive Chairman of Neurotech 8/6/2013 8:09:30 AM
Mat Kandell Joins Neurotech as Sales Product Specialist 2/4/2013 9:37:57 AM
Sorin Group S.p.A. (SRN) Acquires Catholic University of Leuven Spin-Off Neurotech 11/12/2012 8:04:06 AM
Neurotech Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain 7/25/2012 9:05:47 AM